Difference between revisions of "Winkler-Stuck 2005 J Neural Transm"
| Line 7: | Line 7: | ||
|abstract=The origin and tissue distribution of the mitochondrial dysfunction in Parkinsonrsquos disease (PD) remains still a matter of controversy. To re-evaluate a probably free radical-born, generalized mitochondrial impairment in PD, we applied optimized enzymatic assays, high resolution oxygraphic measurements of permeabilized muscle fibers, and application of metabolic control analysis to skeletal muscle samples of 19 PD patients and 36 age-matched controls. We detected decreased activities of respiratory chain complexes I and IV being accompanied by increased flux control coefficients of complexes I and IV on oxygen consumption of muscle fibers. We further investigated if randomly distributed point mutations in two discrete regions of the mitochondrial DNA are increased in PD muscle, and if they could contribute to the mitochondrial impairment. Our data confirm the previously debated presence of a mild mitochondrial defect in skeletal muscle of patients with PD which is accompanied with an about 1.5 to 2-fold increase of point mutated mtDNA. | |abstract=The origin and tissue distribution of the mitochondrial dysfunction in Parkinsonrsquos disease (PD) remains still a matter of controversy. To re-evaluate a probably free radical-born, generalized mitochondrial impairment in PD, we applied optimized enzymatic assays, high resolution oxygraphic measurements of permeabilized muscle fibers, and application of metabolic control analysis to skeletal muscle samples of 19 PD patients and 36 age-matched controls. We detected decreased activities of respiratory chain complexes I and IV being accompanied by increased flux control coefficients of complexes I and IV on oxygen consumption of muscle fibers. We further investigated if randomly distributed point mutations in two discrete regions of the mitochondrial DNA are increased in PD muscle, and if they could contribute to the mitochondrial impairment. Our data confirm the previously debated presence of a mild mitochondrial defect in skeletal muscle of patients with PD which is accompanied with an about 1.5 to 2-fold increase of point mutated mtDNA. | ||
|keywords=Mitochondria, mitochondrial DNA, Oxidative phosphorylation, Parkinson's disease, Skeletal muscle | |keywords=Mitochondria, mitochondrial DNA, Oxidative phosphorylation, Parkinson's disease, Skeletal muscle | ||
}} | }} | ||
{{Template:Cited in Gnaiger 2000 BEC MitoPathways}} | |||
{{Labeling | {{Labeling | ||
|diseases=Parkinson's | |diseases=Parkinson's | ||
| Line 19: | Line 20: | ||
|instruments=Oxygraph-2k | |instruments=Oxygraph-2k | ||
|additional=BEC 2020.2 | |additional=BEC 2020.2 | ||
}} | }} | ||
Revision as of 18:46, 3 January 2021
| Winkler-Stuck K, Kirches E, Mawrin C, Dietzmann K, Lins H, Wallesch CW, Kunz WS, Wiedemann FR (2005) Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson's disease. J Neural Transm 112:499-518. |
Winkler-Stuck K, Kirches E, Mawrin C, Dietzmann K, Lins H, Wallesch CW, Kunz WS, Wiedemann FR (2005) J Neural Transm
Abstract: The origin and tissue distribution of the mitochondrial dysfunction in Parkinsonrsquos disease (PD) remains still a matter of controversy. To re-evaluate a probably free radical-born, generalized mitochondrial impairment in PD, we applied optimized enzymatic assays, high resolution oxygraphic measurements of permeabilized muscle fibers, and application of metabolic control analysis to skeletal muscle samples of 19 PD patients and 36 age-matched controls. We detected decreased activities of respiratory chain complexes I and IV being accompanied by increased flux control coefficients of complexes I and IV on oxygen consumption of muscle fibers. We further investigated if randomly distributed point mutations in two discrete regions of the mitochondrial DNA are increased in PD muscle, and if they could contribute to the mitochondrial impairment. Our data confirm the previously debated presence of a mild mitochondrial defect in skeletal muscle of patients with PD which is accompanied with an about 1.5 to 2-fold increase of point mutated mtDNA. • Keywords: Mitochondria, mitochondrial DNA, Oxidative phosphorylation, Parkinson's disease, Skeletal muscle
Template:Cited in Gnaiger 2000 BEC MitoPathways
Labels: Pathology: Parkinson's Stress:Mitochondrial disease Organism: Human Tissue;cell: Skeletal muscle Preparation: Permeabilized tissue Enzyme: Complex I, Complex IV;cytochrome c oxidase
Coupling state: OXPHOS
HRR: Oxygraph-2k
BEC 2020.2
